ClinicalTrials.Veeva

Menu

What Embryoselection for What Chance of Success ? EmbryoSelect Study

U

University Hospital of Bordeaux

Status

Active, not recruiting

Conditions

Infertility

Treatments

Other: Embryo culture in time lapse technology (TLT)
Other: Embryo culture in conventional incubator

Study type

Interventional

Funder types

Other

Identifiers

NCT04484181
CHUBX 2019/50

Details and patient eligibility

About

The aim of the research is to evaluate the results of the first in vitro fertilization (IVF) attempt according to the type of embryo culture. From the fertilization to the day 2 transfer, embryos are cultured in standard incubator or in a time lapse technology (TLT). TLT offers an uninterrupted culture environment with a morphokinetic evaluation, whereas culture in standard incubator involves discontinuous morphological embryo evaluation. The principal objective is to compare the live birth rate after the fresh embryo transfer, in a cohort of women less than 39 years-old.

Full description

Embryo evaluation and selection is fundamental in clinical IVF in order to obtain a live birth in a shorter delay as possible, but minimizing the risk of multiple pregnancies. TLT was introduced few years ago in clinical practice and allows the continuous follow up of the embryo development. In IVF centers, embryos are preferentially cultured in TL system with undisturbed environmental conditions. This provides information about the development of the embryos in time intervals of 15min and adds kinetic criteria for embryo evaluation and selection. In conventional incubator, the follow up of embryo development consists in 3 static time point observations. Many reviews and observational studies have discussed the value of time-lapse monitoring but it is as yet unclear, however, whether the TLT improves the results of IVF. It has been suggested that the clinical benefits of applying new technologies should be verified and documented by randomized controlled trials. Moreover, the cumulative live birth rate and the delay for conception were rarely reported. The study aims to evaluate the results of the first IVF attempts comparing classical embryo culture in standard incubator and embryo culture and follow up in TLT. The hypothesis is that the undisturbed culture and the selection based on continuous time-lapse images improve the results of the single embryo fresh transfer and increase the cumulative live birth rate. Patients will be randomized the day of the puncture for the type of culture: standard incubation or TLT. The results of the fresh and successive vitrified-warmed embryo transfer will be prospectively collect and patients will be followed until live birth. The attempt will be considered ended after a live birth, if all the frozen embryos are transferred, after 24 months follow up or after surrender.

Enrollment

500 patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • first IVF/ICSI attempt with fresh transfer,
  • women ≥18 years-old and <39 years-old,
  • signed informed consent

Exclusion criteria

  • attempts with donor,
  • comprehension problem,
  • frozen gametes,
  • BMI>35 kg/m2,
  • history of 3 or more miscarriages,
  • uterine pathology,
  • serodiscordant patients

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

500 participants in 2 patient groups

Embryo culture in time lapse technology (TLT)
Experimental group
Description:
In the TLT group, the selection for transfer was based on morphological and kinetic criteria (with the use of an algorithm). Embryos will be cultured and selected for fresh transfer.
Treatment:
Other: Embryo culture in time lapse technology (TLT)
Embryo culture in conventional incubator
Active Comparator group
Description:
For the standard incubation group, the selection for transfer was based on morphological criteria. Embryos will be cultured and selected for fresh transfer.
Treatment:
Other: Embryo culture in conventional incubator

Trial contacts and locations

2

Loading...

Central trial contact

Lucie Chansel-Debordeaux, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems